comprehensive -WSS

comprehensive

author：entertainment 2025-09-28 23:11:31 - browse：56

Adam's take main illustration — Molly Ferguson/STAT

This week, an encouraging turnaround for Ocular Therapeutix, a chat with Alnylam’s CEO defending changes to the HELIOS-B study and talking up its hypertension treatment, and quick takes on Amylyx and obesity stocks.

A Worst CEO gets some much-needed help

For most of last year, Ocular Therapeutix CEO Antony Mattessich promised shareholders that he was close to nailing down a lucrative pharma partnership that would pay for late-stage clinical trials of the company’s treatments for degenerative eye diseases. The deal never happened. I heard from many Ocular investors who were frustrated and angry about Mattesich’s poor job performance. He ended up earning a spot last year on my worst biopharma CEO list. It was an easy pick.

On Thursday, Ocular announced a meaningful “leadership update.” Mattessich is still the CEO, but let’s just say the company’s board decided to surround him with new executives and retinal experts with proven track records of getting stuff done.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： WuXi out of biotech trade group, U.S. and China relations to blame

hotspot

WSS

WuXi out of biotech trade group, U.S. and China relations to blame

A cyberattack has disrupted hospitals and health care in several states

Pushing for an NIH office for post

The drug industry sees a key ally in the Senate prevail

Gilgo Beach: Police identify another victim in serial killing investigation

RaDonda Vaught links Vanderbilt hospital issues to patient death

leisure time

comprehensive

A Worst CEO gets some much-needed help

explore

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

President Biden's budget: Here's what you might have missed

How one medical school became remarkably diverse

As AI in medicine takes off, can 'human in the loop' prevent harm?

What does generative AI mean for health care? We asked experts

'Ancient DNA,' 23andMe reveal African American ancestries

As demand for Covid shots wanes, Moderna seeks its next success

Microsoft strikes partnership with Duke Health to advance health AI

The high cost of giving birth even with insurance

Wild otter attack leads to woman being airlifted to hospital, 2 others treated for injuries

leisure time

A cyberattack has disrupted hospitals and health care in several states

Dramatically reducing cancer deaths requires the PASTEUR Act

Why scientists need input from humanists on sensitive research

Amid AI frenzy, a top HHS official's quest to create safeguards

Acadia's Nuplazid fails as schizophrenia medicine in Phase 3 study

Steward Health Care Massachusetts hospitals face fiscal disaster

focus

leisure time

hotspot

explore